Metraipolis › archive › dc_8d45f6151f28

Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants — Europe PMC PMID:37880298

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37880298
DOI
10.1038/s41541-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-10-08T14:37:49.656Z
SHA-256 of the archived text
b0b6d0cf9338370979e9b0672db56bfc986587eb5108114a0acda1345cd97808
Stable URL of this page
https://metraipolis.com/documento/dc_8d45f6151f28

How to cite

Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants — Europe PMC PMID:37880298 — Europe PMC (en), https://europepmc.org/article/MED/37880298 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d45f6151f28 (Metraipolis archive dc_8d45f6151f28, sha256 b0b6d0cf9338370979e9b0672db56bfc986587eb5108114a0acda1345cd97808)
BibTeX
@misc{dc8d45f6151f28,
  title = {Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants — Europe PMC PMID:37880298},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37880298},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d45f6151f28; sha256 b0b6d0cf9338370979e9b0672db56bfc986587eb5108114a0acda1345cd97808},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37880298. Agents can read the archived copy with the MCP tool read_document.